Emergent BioSolutions
Premium PartnerIs this your company? Claim this profile
Drug Product
Analytical & Bioanalytical Services
Company Overview
About
Emergent BioSolutions is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Cardiovascular
Endocrinology
Quick Facts
HQ:United States
Founded:1999
Employees:2,194
Capabilities & Services
Core Capabilities
- Sterile Injectable
- Sterile Fill/Finish
- Fill/Finish (Vials)
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Cartridge / Pen
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Asia-Pacific
Manufacturing Facilities
1 site worldwide
Emergent BioSolutions Canada Inc
155 Innovation Drive, Winnipeg, Manitoba R, 3T5Y3
Site Capabilities
4 capabilitiesANALYSIS
LABEL
MANUFACTURE
PACK
Regulatory Approvals
Drug Approval QQQQK7
EMA · #APR-DOB8QEV9 · 2022-04-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-D837CIFH
Issued: 2020-07-18
Expires: 2025-04-10
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-GPBQ3SQJ
Issued: 2020-05-01
Expires: 2025-02-23
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-8TANIVCE
Issued: 2020-08-09
Expires: 2025-05-22
Loading CDMO intelligence...
Key facts about Emergent BioSolutions
- Emergent BioSolutions is headquartered in the United States.
- Emergent BioSolutions was founded in 1999.
- Emergent BioSolutions has 2,194 employees.
- Emergent BioSolutions has one manufacturing site listed on CDMO Hub, in Winnipeg, Canada.
- Emergent BioSolutions's capabilities include Sterile Injectable, Sterile Fill/Finish and Fill/Finish (Vials).
Find CDMOs like Emergent BioSolutions
Directory pages this company appears in, each with the full list of matching manufacturers.